World Psoriasis Day: Advancing Early Detection of Psoriatic Arthritis
Every year on 29 October, World Psoriasis Day raises awareness of the 125 million people worldwide living with psoriatic arthritis (PsA), a chronic condition affecting skin, joints, and quality of life.
This year's observance highlights European research, powered by innovation and collaboration, paving the way for earlier diagnosis and personalised treatment of PsA through projects like iPROLEPSIS.
iPROLEPSIS Project
The iPROLEPSIS project, funded under the Horizon Europe programme, aims to revolutionise PsA management by developing advanced tools for early detection, long before irreversible joint damage occurs.
Psoriatic arthritis often develops in people who already have psoriasis, but its early symptoms can be subtle or mistaken for other conditions.
Delayed diagnosis can lead to permanent joint deformities and reduced mobility, which iPROLEPSIS hopes to change by creating a predictive tool.
Author's summary: iPROLEPSIS project advances early detection of psoriatic arthritis.